Application YC di Valink Therapeutics

Winter 2021Active

Valink Therapeutics ha partecipato a Y Combinator nel batch Winter 2021 come azienda Healthcare. Sotto: cosa fa l'azienda, chi l'ha fondata e la sua application a YC, ricostruita domanda per domanda nel form reale di YC.

Batch YC: Winter 2021
Settore: HealthcareTherapeutics
Dimensione team: 15
Stato: Active
Lanciata: 2021

Founder

Arne ScheuFounder
Irsyad KhairilFounder

Cosa fa Valink Therapeutics

Valink Therapeutics develops next generation antibody-based therapeutics. We identify novel mechanism of action from known targets by incorporating multiple antibody modifications at once, rapidly and scalable generating complex drug candidates (bi-/multispecificity, multivalency and drug-conjugation in a single discovery process). Our research focus is on solid tumours poorly addressed by immunotherapy.

Application YC di Valink Therapeutics, ricostruita

Domanda per Y Combinator

Valink Therapeutics, batch Winter 2021. Le vere domande del form, risposte da dati pubblici.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Valink Therapeutics

Describe what your company does in 50 characters or less.

Discovering bispecific antibody drug-conjugates against cancer

What is your company going to make? Please describe your product and what it does or will do.

We're building a platform to discover bispecific antibody drug-conjugates (BsADCs) targeting solid tumors that current immunotherapies fail to address. Our approach combines multiple antibody modifications simultaneously - bi- and multispecificity, multivalency, and drug conjugation - within a single discovery process. This enables us to rapidly generate complex candidates with novel mechanisms of action.

Where do you live now, and where would the company be based after YC?

We live and work in Boston, MA, and we plan to keep the company based there after YC.

Explain your decision regarding location.

Boston is a top biotech hub with access to talent, labs, and partners critical to advancing antibody therapeutics. We want to be where the expertise and infrastructure are.

21 risposte in più nell'application completa

Founders, Progress, Idea, Equity, Curious, Batch Preference sono nella versione completa. Crea un account gratuito per aprirla in YC Insights, accanto a ogni altro batch YC.

Vedi domanda completa

Domande Frequenti

Questa è l'application YC reale di Valink Therapeutics?

No. Y Combinator mantiene private le application inviate. Questa è una ricostruzione: le domande del form YC reale, a cui si è risposto usando i dati pubblici di Valink Therapeutics (note di lancio, background dei founder, descrizione del prodotto). Mostra come un'azienda come Valink Therapeutics si presenterebbe a YC, non il testo che hanno inviato.

A quale batch YC apparteneva Valink Therapeutics?

Valink Therapeutics apparteneva al batch Winter 2021 di Y Combinator.

Chi ha fondato Valink Therapeutics?

Valink Therapeutics è stato fondato da Arne Scheu, Irsyad Khairil.

Cosa fa Valink Therapeutics?

Discovering bispecific antibody drug-conjugates (BsADC) against cancer

Come leggo la ricostruzione completa della application?

Crea un account Round Funded gratuito. La versione completa di 26 risposte della application di Valink Therapeutics, e di ogni altro batch YC, è in YC Insights.